Scarica l'app Stockscreener
75.80
1.33%
-1.02
Dopo l'orario di chiusura:
75.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
PTC Therapeutics Inc (PTCT) Balance Sheet - TradingKey
PTC Therapeutics Inc (PTCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PTC Therapeutics Inc (PTCT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PTC Therapeutics Inc (PTCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PTC Therapeutics to Participate at Upcoming Investor Conferences - GuruFocus
PTC Therapeutics Inc (PTCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PTC Therapeutics, Inc. Revenue Breakdown – BOATS:PTCT - TradingView
PTC Therapeutics Inc (PTCT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PTCT|PTC Therapeutics Inc|Price:76.820|Chg%:-1.630 - TradingKey
PTC Therapeutics Inc (PTCT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PTCT5396017 Bond Profile — Key Metrics - TradingView
Will PTC Therapeutics (PTCT) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Barclays Remains a Buy on PTC Therapeutics (PTCT) - The Globe and Mail
Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120 - Moomoo
Responsive Playbooks and the PTCT Inflection - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
PTCT Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Is PTC Therapeutics (PTCT) Cheap On Fast Track News For PTC518? - Sahm
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix - TradingView
Reasons why investors should consider betting on PTC stock now - MSN
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - Sahm
Form 4 PTC Therapeutics Inc For: 16 July By Investing.com - Investing.com Nigeria
PTC Therapeutics CFO Pierre Gravier sells $280,742 in shares By Investing.com - Investing.com South Africa
PTC Therapeutics schedules second-quarter 2026 results webcast conference call - Bitget
PTC Therapeutics CFO Pierre Gravier sells $280,742 in shares - Investing.com
PTC Therapeutics (PTCT) CFO auto-sells 3,494 shares to cover RSU taxes - Stock Titan
PTCT Maintained by Cantor FitzgeraldPrice Target Raised to $1 - GuruFocus
Cantor Fitzgerald raises PTC Therapeutics stock price target on Sephience outlook - Investing.com Canada
PTC Therapeutics Sets July 30 Webcast for Business Update - Stock Titan
Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $130 - Moomoo
PTC Therapeutics (PTCT) Gets a Buy from Bank of America Securities - The Globe and Mail
Cantor Fitzgerald reiterates Overweight on PTC Therapeutics stock By Investing.com - Investing.com Canada
What PTC Therapeutics (PTCT)'s Q1 Beat and Sephience Outlook Shift Mean For Shareholders - Sahm
Form 144 PTC THERAPEUTICS For: 14 July By Investing.com - Investing.com Nigeria
PTC THERAPEUTICS, INC. SEC Filing (Jul 14, 2026) - Stock Titan
PTC Therapeutics (PTCT) Q1 2025 earnings summary - Quartr
PTC Therapeutics (PTCT) 2024 Wells Fargo Healthcare Conference Summary - Quartr
Form 4 PTC Therapeutics Inc For: 13 July By Investing.com - Investing.com South Africa
PTC Therapeutics chief technical ops officer sells $222,376 in shares - Investing.com UK
Mary L. Smith, director at PTC Therapeutics, sells $1.43m in stock - Investing.com UK
PTC Therapeutics chief technical ops officer sells $222,376 in shares By Investing.com - Investing.com Nigeria
What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million - The Motley Fool
What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million - The Motley Fool
Mary L. Smith, director at PTC Therapeutics, sells $1.43m in stock By Investing.com - Investing.com South Africa
PTC Therapeutics (PTCT) director trades 15,834 shares via option exercise and sale - Stock Titan
J.P. Morgan Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $91 - Moomoo
PTC Therapeutics (PTCT) On Russell Index Inclusion And Pipeline Optimism With Fair Value In Focus - simplywall.st
PTC Therapeutics Inc (PTCT) - MSN
PTC Therapeutics (PTCT) Q3 2024 earnings summary - Quartr
PTC Therapeutics (PTCT) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
PTC Therapeutics (PTCT) Q2 2024 earnings summary - Quartr
PTC Therapeutics (PTCT) Stock May Be Fully Priced After Rare Disease Data - Yahoo Finance
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):